Clinical Trials Insight: 700028567
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 16 Nov 2007
At a glance
- Drugs Glatiramer acetate (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Sponsors Teva Pharmaceutical Industries
- 16 Nov 2007 New trial record.
- 13 Oct 2007 Teva presented 16-year follow-up data at the 23rd annual ECTRIMS congress.